BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ngambenjawong C, Cieslewicz M, Schellinger JG, Pun SH. Synthesis and evaluation of multivalent M2pep peptides for targeting alternatively activated M2 macrophages. J Control Release 2016;224:103-11. [PMID: 26772876 DOI: 10.1016/j.jconrel.2015.12.057] [Cited by in Crossref: 27] [Cited by in F6Publishing: 32] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Yang M, Wang B, Yin Y, Ma X, Tang L, Zhang Y, Fan Q, Yin T, Wang Y. PTN-PTPRZ1 signaling axis blocking mediates tumor microenvironment remodeling for enhanced glioblastoma treatment. Journal of Controlled Release 2023;353:63-76. [DOI: 10.1016/j.jconrel.2022.11.025] [Reference Citation Analysis]
2 Chowdhury S, Trivedi AK. Origin, production and molecular determinants of macrophages for their therapeutic targeting. Cell Biol Int 2022. [PMID: 36183367 DOI: 10.1002/cbin.11914] [Reference Citation Analysis]
3 Zhu H, Ren F, Wang T, Jiang Z, Sun Q, Li Z. Targeted Immunoimaging of Tumor-Associated Macrophages in Orthotopic Glioblastoma by the NIR-IIb Nanoprobes. Small 2022;:e2202201. [PMID: 35771091 DOI: 10.1002/smll.202202201] [Reference Citation Analysis]
4 Donoso‐meneses D, Figueroa‐valdés AI, Georges N, Tobar HE, Alcayaga‐miranda F. Turning adversity into opportunity: Small extracellular vesicles as nanocarriers for tumor‐associated macrophages re‐education. Bioengineering & Transla Med. [DOI: 10.1002/btm2.10349] [Reference Citation Analysis]
5 Karami Fath M, Babakhaniyan K, Zokaei M, Yaghoubian A, Akbari S, Khorsandi M, Soofi A, Nabi-Afjadi M, Zalpoor H, Jalalifar F, Azargoonjahromi A, Payandeh Z, Alagheband Bahrami A. Anti-cancer peptide-based therapeutic strategies in solid tumors. Cell Mol Biol Lett 2022;27:33. [PMID: 35397496 DOI: 10.1186/s11658-022-00332-w] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
6 Li Y, Zhang X, Zeng X, Wang S, Wang H. Tumor-Associated Macrophages: Therapeutic Targets of Cancer. Macrophage Targeted Delivery Systems 2022. [DOI: 10.1007/978-3-030-84164-5_13] [Reference Citation Analysis]
7 Shi L, Gu H. Emerging Nanoparticle Strategies for Modulating Tumor-Associated Macrophage Polarization. Biomolecules 2021;11:1912. [PMID: 34944555 DOI: 10.3390/biom11121912] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
8 Yang Y, Guo T, Xu J, Xiong Y, Cui X, Ke Y, Wang C. Micelle nanovehicles for co-delivery of Lepidium meyenii Walp. (maca) polysaccharide and chloroquine to tumor-associated macrophages for synergistic cancer immunotherapy. Int J Biol Macromol 2021;189:577-89. [PMID: 34450149 DOI: 10.1016/j.ijbiomac.2021.08.155] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
9 Chen S, Qin F, Wang M, Wei Y, Qian Z, Wei X. Nanoparticles targeting tumor-associated macrophages: A novel anti-tumor therapy. Nano Res 2022;15:2177-95. [DOI: 10.1007/s12274-021-3781-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
10 Yang Y, Guo J, Huang L. Tackling TAMs for Cancer Immunotherapy: It's Nano Time. Trends Pharmacol Sci 2020;41:701-14. [PMID: 32946772 DOI: 10.1016/j.tips.2020.08.003] [Cited by in Crossref: 30] [Cited by in F6Publishing: 35] [Article Influence: 30.0] [Reference Citation Analysis]
11 Salah A, Li Y, Wang H, Qi N, Wu Y. Macrophages as a Double-Edged Weapon: The Use of Macrophages in Cancer Immunotherapy and Understanding the Cross-Talk Between Macrophages and Cancer. DNA Cell Biol 2021;40:429-40. [PMID: 33481665 DOI: 10.1089/dna.2020.6087] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
12 Izci M, Maksoudian C, Manshian BB, Soenen SJ. The Use of Alternative Strategies for Enhanced Nanoparticle Delivery to Solid Tumors. Chem Rev 2021;121:1746-803. [PMID: 33445874 DOI: 10.1021/acs.chemrev.0c00779] [Cited by in Crossref: 89] [Cited by in F6Publishing: 105] [Article Influence: 89.0] [Reference Citation Analysis]
13 Zhukova OV, Kovaleva TF, Arkhipova EV, Ryabov SA, Mukhina IV. Tumor-associated macrophages: Role in the pathological process of tumorigenesis and prospective therapeutic use (Review). Biomed Rep 2020;13:47. [PMID: 32934819 DOI: 10.3892/br.2020.1354] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
14 Scodeller P, Asciutto EK. Targeting Tumors Using Peptides. Molecules 2020;25:E808. [PMID: 32069856 DOI: 10.3390/molecules25040808] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 15.5] [Reference Citation Analysis]
15 Zhang L, Huang Y, Lindstrom AR, Lin TY, Lam KS, Li Y. Peptide-based materials for cancer immunotherapy. Theranostics 2019;9:7807-25. [PMID: 31695802 DOI: 10.7150/thno.37194] [Cited by in Crossref: 39] [Cited by in F6Publishing: 45] [Article Influence: 13.0] [Reference Citation Analysis]
16 Zafar S, Beg S, Panda SK, Rahman M, Alharbi KS, Jain GK, Ahmad FJ. Novel therapeutic interventions in cancer treatment using protein and peptide-based targeted smart systems. Semin Cancer Biol 2021;69:249-67. [PMID: 31442570 DOI: 10.1016/j.semcancer.2019.08.023] [Cited by in Crossref: 16] [Cited by in F6Publishing: 21] [Article Influence: 5.3] [Reference Citation Analysis]
17 Lin Y, Xu J, Lan H. Tumor-associated macrophages in tumor metastasis: biological roles and clinical therapeutic applications. J Hematol Oncol. 2019;12:76. [PMID: 31300030 DOI: 10.1186/s13045-019-0760-3] [Cited by in Crossref: 447] [Cited by in F6Publishing: 488] [Article Influence: 149.0] [Reference Citation Analysis]
18 Pang L, Pei Y, Uzunalli G, Hyun H, Lyle LT, Yeo Y. Surface Modification of Polymeric Nanoparticles with M2pep Peptide for Drug Delivery to Tumor-Associated Macrophages. Pharm Res 2019;36:65. [PMID: 30859335 DOI: 10.1007/s11095-019-2596-5] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 10.0] [Reference Citation Analysis]
19 Norton KA, Gong C, Jamalian S, Popel AS. Multiscale Agent-Based and Hybrid Modeling of the Tumor Immune Microenvironment. Processes (Basel) 2019;7:37. [PMID: 30701168 DOI: 10.3390/pr7010037] [Cited by in Crossref: 66] [Cited by in F6Publishing: 74] [Article Influence: 22.0] [Reference Citation Analysis]
20 Zhu X, Deng X, Lu C, Chen Y, Jie L, Zhang Q, Li W, Wang Z, Du Y, Yu R. SPIO-loaded nanostructured lipid carriers as liver-targeted molecular T2-weighted MRI contrast agent. Quant Imaging Med Surg 2018;8:770-80. [PMID: 30306057 DOI: 10.21037/qims.2018.09.03] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
21 Zhang C, Wu W, Li R, Qiu W, Zhuang Z, Cheng S, Zhang X. Peptide‐Based Multifunctional Nanomaterials for Tumor Imaging and Therapy. Adv Funct Mater 2018;28:1804492. [DOI: 10.1002/adfm.201804492] [Cited by in Crossref: 67] [Cited by in F6Publishing: 68] [Article Influence: 16.8] [Reference Citation Analysis]
22 Qian W, Qian M, Wang Y, Huang J, Chen J, Ni L, Huang Q, Liu Q, Gong P, Hou S, Zhu H, Jia Z, Shen D, Zhu C, Jiang R, Sun J, Yao J, Tang Z, Ji X, Shi J, Huang R, Shi W. Combination Glioma Therapy Mediated by a Dual-Targeted Delivery System Constructed Using OMCN-PEG-Pep22/DOX. Small 2018;14:e1801905. [PMID: 30346089 DOI: 10.1002/smll.201801905] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 6.0] [Reference Citation Analysis]
23 Min KA, Maharjan P, Ham S, Shin MC. Pro-apoptotic peptides-based cancer therapies: challenges and strategies to enhance therapeutic efficacy. Arch Pharm Res 2018;41:594-616. [PMID: 29804279 DOI: 10.1007/s12272-018-1038-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
24 Le Joncour V, Laakkonen P. Seek & Destroy, use of targeting peptides for cancer detection and drug delivery. Bioorg Med Chem 2018;26:2797-806. [PMID: 28893601 DOI: 10.1016/j.bmc.2017.08.052] [Cited by in Crossref: 54] [Cited by in F6Publishing: 54] [Article Influence: 10.8] [Reference Citation Analysis]
25 Janjic JM, Gorantla VS. Peripheral Nerve Nanoimaging: Monitoring Treatment and Regeneration. AAPS J 2017;19:1304-16. [PMID: 28779380 DOI: 10.1208/s12248-017-0129-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
26 Ngambenjawong C, Pun SH. Multivalent polymers displaying M2 macrophage-targeting peptides improve target binding avidity and serum stability. ACS Biomater Sci Eng 2017;3:2050-3. [PMID: 29430522 DOI: 10.1021/acsbiomaterials.7b00332] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
27 Sawa-Wejksza K, Kandefer-Szerszeń M. Tumor-Associated Macrophages as Target for Antitumor Therapy. Arch Immunol Ther Exp (Warsz) 2018;66:97-111. [PMID: 28660349 DOI: 10.1007/s00005-017-0480-8] [Cited by in Crossref: 104] [Cited by in F6Publishing: 118] [Article Influence: 20.8] [Reference Citation Analysis]
28 Song E, Gaudin A, King AR, Seo YE, Suh HW, Deng Y, Cui J, Tietjen GT, Huttner A, Saltzman WM. Surface chemistry governs cellular tropism of nanoparticles in the brain. Nat Commun 2017;8:15322. [PMID: 28524852 DOI: 10.1038/ncomms15322] [Cited by in Crossref: 50] [Cited by in F6Publishing: 52] [Article Influence: 10.0] [Reference Citation Analysis]
29 Ngambenjawong C, Gustafson HH, Pun SH. Progress in tumor-associated macrophage (TAM)-targeted therapeutics. Adv Drug Deliv Rev 2017;114:206-21. [PMID: 28449873 DOI: 10.1016/j.addr.2017.04.010] [Cited by in Crossref: 291] [Cited by in F6Publishing: 322] [Article Influence: 58.2] [Reference Citation Analysis]
30 Yong SB, Song Y, Kim HJ, Ain QU, Kim YH. Mononuclear phagocytes as a target, not a barrier, for drug delivery. J Control Release 2017;259:53-61. [PMID: 28108325 DOI: 10.1016/j.jconrel.2017.01.024] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 5.0] [Reference Citation Analysis]
31 Song JX, Dian ZJ, Wen Y, Mei F, Li RW, Sa YL. Assessment of the Number and Phenotype of Macrophages in the Human BMB Samples of CML. Biomed Res Int 2016;2016:8086398. [PMID: 27999815 DOI: 10.1155/2016/8086398] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
32 Truman R, Locke CJ. Gazelles, unicorns, and dragons battle cancer through the Nanotechnology Startup Challenge. Cancer Nanotechnol 2016;7:4. [PMID: 27358656 DOI: 10.1186/s12645-016-0017-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
33 Ngambenjawong C, Gustafson HH, Pineda JM, Kacherovsky NA, Cieslewicz M, Pun SH. Serum Stability and Affinity Optimization of an M2 Macrophage-Targeting Peptide (M2pep). Theranostics 2016;6:1403-14. [PMID: 27375788 DOI: 10.7150/thno.15394] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 4.3] [Reference Citation Analysis]